TOHO HOLDINGS
We manage the corporate venture capital fund of TOHO HOLDINGS that leverages its extensive healthcare assets, including its pharmaceutical distribution network, dispensing pharmacy channels, and manufacturing and data infrastructure, and serves as a co-creation CVC platform to help portfolio companies achieve commercialization and social implementation.
TOHO Ventures
- Fund size
- JPY 10B
- Term
- 10 years
- General partner
- Global Brain Corporation
- Target
- Drug discovery, medical devices, etc.
- Objective
- The fund focuses primarily on drug discovery and biotechnology, investing in leading startups based mainly outside Japan. It will support next-generation platforms that dramatically enhance the productivity and success rate of drug development—powered by AI, data science, and breakthroughs in cellular and genetic engineering—as well as new therapeutic modalities that enable curative treatments for diseases.